The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

This sale represented 6.76% of De Backer's total holdings at the time of the transaction. The transaction involved only direct holdings, with no activity reported in indirect accounts such as the ...

This week brings a fresh batch of Malayalam films to OTT platforms from dystopian thrillers and social dramas to feel-good stories and supernatural tales. Here is a quick look at some of the newly ...

Malayalam OTT releases this week: A new set of original and OTT releases is here. New Malayalam releases will be streaming online on OTT platforms like JioHotstar, Netflix, Sun NXT, ZEE5 and more.

Mordecai and Rigby are so back. The comedic slackers from Cartoon Network's Emmy-winning animated series "Regular Show" are set to return. "Regular Show: The Lost Tapes" will see the pair back for ...

Malayalam has officially been declared the official language of Kerala, after Governor Rajendra Vishwanath Arlekar signed the Malayalam Language Bill, 2025. With the Governor’s assent, the legislation ...

Overall survival from the phase 2 trial of abiraterone, olaparib, or abiraterone + olaparib in first-line metastatic castration-resistant prostate cancer (mCRPC) with DNA repair defects (BRCAAway).

Tubi is in its "cartoon era." In a Feb. 13 post on X, the free on-demand streaming service revealed it was adding 100 animated shows to its platform beginning March 1. Founded in 2014, Tubi offers ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Astellas Pharma has agreed to co-develop and co-commercialize Vir Biotechnology’s most advanced immuno-oncology asset, the prostate cancer candidate VIR-5500, through a collaboration that could ...

UKRAINE - 2022/01/23: In this photo illustration, a Vir Biotechnology logo is seen on a smartphone and a computer screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images) ...

Vir Biotechnology, Inc. (VIR) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to a loss of $0.76 per share a year ago. These ...